spädningsvätska för parenteral användning clinical trials

A phase 2, randomised, double-blind, placebo-controlled trial to evaluate safety and local tolerability of four weekly administrations of A24110He in subjects with elevated triglyceride plasma concentrations

This study is testing a new medicine called A24110He for people with very high levels of a type of fat (triglycerides) in their blood. We want to see if it's safe and how the body handles it. Participants will receive either the new medicine or a dummy treatment (placebo).